Stoter G - Search Results

1

5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.

van der Gaast A, Verweij J, Planting AS, Stoter G. van der Gaast A, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1988 Apr;24(4):765-8. doi: 10.1016/0277-5379(88)90312-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383976

2

A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer.

Polee MB, Sparreboom A, Eskens FA, Hoekstra R, van de Schaaf J, Verweij J, Stoter G, van der Gaast A. Polee MB, et al. Among authors: stoter g. Clin Cancer Res. 2004 Mar 15;10(6):1928-34. doi: 10.1158/1078-0432.ccr-03-0319. Clin Cancer Res. 2004. PMID: 15041708 Free article. Clinical Trial.

3

A phase II study of high dose ifosfamide in metastatic colorectal cancer.

Planting AS, van der Burg ME, Hoff AM, Verweij J, Stoter G. Planting AS, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1989 Jan;25(1):139-40. doi: 10.1016/0277-5379(89)90062-x. Eur J Cancer Clin Oncol. 1989. PMID: 2920760 No abstract available.

4

Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.

Jansen RL, van der Burg ME, Verweij J, Stoter G. Jansen RL, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1131-3. doi: 10.1016/0277-5379(87)90145-3. Eur J Cancer Clin Oncol. 1987. PMID: 3115787

5

Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer.

Dees A, Verweij J, van Putten WL, Stoter G. Dees A, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1343-7. doi: 10.1016/0277-5379(87)90118-0. Eur J Cancer Clin Oncol. 1987. PMID: 3119346

6

Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group.

Verweij J, Alexieva-Figusch J, de Boer MF, Reichgelt B, Stoter G. Verweij J, et al. Among authors: stoter g. Eur J Cancer Clin Oncol. 1988 Apr;24(4):795-6. doi: 10.1016/0277-5379(88)90318-5. Eur J Cancer Clin Oncol. 1988. PMID: 3383981 No abstract available.

7

Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.

van der Gaast A, Verweij J, Planting AS, Hop WC, Stoter G. van der Gaast A, et al. Among authors: stoter g. J Clin Oncol. 1995 Jul;13(7):1720-5. doi: 10.1200/JCO.1995.13.7.1720. J Clin Oncol. 1995. PMID: 7541451 Clinical Trial.

8

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.

Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: stoter g. Ann Oncol. 1995 Feb;6(2):190-2. doi: 10.1093/oxfordjournals.annonc.a059117. Ann Oncol. 1995. PMID: 7786826 Free article. Clinical Trial.

9

Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.

de Wit R, van der Burg ME, van den Gaast A, Logmans A, Stoter G, Verweij J. de Wit R, et al. Among authors: stoter g. Ann Oncol. 1994 Sep;5(7):656-7. doi: 10.1093/oxfordjournals.annonc.a058942. Ann Oncol. 1994. PMID: 7993845 Free article. Clinical Trial.

10

Weekly high-dose cisplatin in malignant pleural mesothelioma.

Planting AS, Schellens JH, Goey SH, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: stoter g. Ann Oncol. 1994 Apr;5(4):373-4. doi: 10.1093/oxfordjournals.annonc.a058846. Ann Oncol. 1994. PMID: 8075038 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters